In our study, we found that LAPTM5 promoted proliferation, migration, and invasion of ccRCC cells in vitro and promoted tumor growth and survival in vivo; however, the underlying mechanisms remain unknown. Here, LAPTM5 is linked to nonpapillary renal cell carcinoma.